How should a patient who has been taking 25 mg dothiepin (dosulepin) for 5 years be tapered off the medication?

Tapering Dothiepin (Dosulepin) After 5 Years of Use

For a patient on 25 mg dothiepin for 5 years, implement a very gradual hyperbolic taper over several months, reducing by approximately 10% of the current dose every 2-4 weeks, with the final reductions requiring doses as small as 1-2 mg before complete discontinuation.

Why This Approach

Dothiepin (dosulepin) is a tricyclic antidepressant (TCA), and while the provided evidence focuses primarily on opioids and benzodiazepines, the pharmacological principles of tapering psychotropic medications apply directly here. The 25 mg dose is relatively low, but 5 years of continuous use creates significant physiological dependence requiring careful withdrawal management.

Specific Tapering Protocol

Initial Phase (Weeks 1-8)

• Week 0-2: Reduce from 25 mg to 22.5 mg (10% reduction)
• Week 2-4: Reduce to 20 mg (11% reduction from 22.5 mg)
• Week 4-6: Reduce to 18 mg (10% reduction)
• Week 6-8: Reduce to 16 mg (11% reduction)

Middle Phase (Weeks 8-16)

• Continue 10% reductions every 2 weeks: 16 mg → 14 mg → 12.5 mg → 11 mg → 10 mg

Final Phase (Weeks 16-24+)

• Critical: As you approach lower doses, the reductions become smaller in absolute terms but maintain the same 10% proportionate decrease
• 10 mg → 9 mg → 8 mg → 7 mg → 6 mg → 5 mg → 4.5 mg → 4 mg → 3.5 mg → 3 mg → 2.5 mg → 2 mg → 1.5 mg → 1 mg → 0.5 mg → stop

The hyperbolic tapering principle 1 demonstrates that equal dose reductions produce increasingly large pharmacological effects as doses decrease. This is why the final milligrams are the most critical and require the smallest absolute reductions.

Practical Implementation

Obtaining Small Doses

• Request liquid formulation from pharmacy if available
• Consider compounded preparations for doses below 5 mg
• Some patients dissolve tablets in water to create measured portions for very small doses 2, 3

Monitoring Schedule

• Weeks 1-4: Weekly check-ins (phone or in-person)
• Weeks 4-12: Every 2 weeks
• Weeks 12+: Every 2-4 weeks, adjusting based on symptoms 3

Withdrawal Symptoms to Monitor

Physical Symptoms (from TCA withdrawal)

• Flu-like symptoms (nausea, headache, fatigue)
• Dizziness, vertigo
• Electric shock sensations ("brain zaps")
• Sleep disturbances
• Gastrointestinal upset

Psychological Symptoms

• Anxiety, irritability
• Mood instability
• Difficulty concentrating
• Emotional lability

Critical distinction: Withdrawal symptoms typically emerge within 2-5 days of dose reduction and improve within 1-2 weeks. If symptoms persist beyond 2 weeks or worsen progressively, consider relapse of underlying condition rather than withdrawal 4.

Adjusting the Taper

If Withdrawal Symptoms Are Severe

• Pause the taper at current dose for 2-4 weeks
• If symptoms don't improve, increase back to previous tolerated dose
• Resume tapering at slower rate (5% reductions every 3-4 weeks) 2, 3

If Taper Is Well-Tolerated

• Some patients may accelerate after the first few successful reductions
• However, never skip the lowest doses - always prescribe progressively smaller final doses 5
• The first dose reduction is critical and predicts success 5

Important Caveats

Drug Interactions

The FDA label 6 warns that dothiepin is metabolized by CYP2D6. If the patient is taking:

• SSRIs (fluoxetine, paroxetine, sertraline): These inhibit CYP2D6 and increase dothiepin levels, making withdrawal potentially more complex
• Cimetidine: Increases TCA levels significantly
• Alcohol: Potentiates effects and should be avoided during taper

Contraindications to Rapid Taper

• Never abruptly discontinue 6
• History of severe withdrawal symptoms from prior attempts
• Concurrent benzodiazepine or other CNS depressant use
• Significant psychiatric comorbidity (requires psychiatric consultation)

When to Refer

• Patient develops suicidal ideation during taper 6
• Severe withdrawal symptoms unresponsive to dose adjustment
• Unclear whether symptoms represent withdrawal vs. relapse
• Patient has concurrent substance use disorder

Patient Education Points

1. Set realistic expectations: This process will take 6-12 months minimum, possibly longer
2. Withdrawal is not relapse: Temporary discomfort during tapering doesn't mean the original condition has returned
3. Flexibility is key: The schedule can be slowed but shouldn't be rushed
4. Support matters: Involve family/caregivers in monitoring 6
5. No shame in pausing: Holding at a dose or stepping back up is part of successful tapering, not failure

Documentation

Create a written taper agreement including:

• Specific dose reduction schedule
• Expected withdrawal symptoms and management plan
• Contact protocol if problems arise
• Contingency plan if taper fails (may include longer taper timeline or maintenance at low dose) 7

The 25 mg dose is low enough that complete discontinuation is achievable for most patients, but the 5-year duration mandates patience and individualized pacing based on tolerance of each reduction.